Asset Details
Do you wish to reserve the book?
Migraine patients visiting Chinese medicine hospital: Protocol for a prospective, registry-based, real-world observational cohort study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Migraine patients visiting Chinese medicine hospital: Protocol for a prospective, registry-based, real-world observational cohort study
Do you wish to request the book?
Migraine patients visiting Chinese medicine hospital: Protocol for a prospective, registry-based, real-world observational cohort study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Migraine patients visiting Chinese medicine hospital: Protocol for a prospective, registry-based, real-world observational cohort study
2022
Overview
Migraine is a disabling, recurrent headache disorder with complex comorbidities. Conventional treatments for migraine are unsatisfactory, with side effects and limited effectiveness. Chinese herbal medicine (CHM) has been used as an alternative or complementary treatment option for migraine in China. Currently, the existing evidence of benefit of CHM for migraine has been generated from randomised clinical trials using standardised intervention with a focus on internal validity hence with limited external validity. Moreover, CHM individualised intervention design, patients' preferences and concerns, and clinicians' experience are critical to clinical decision making and therapeutic success. This real-world observational study aims to gather practice-based evidence of effects and safety of CHM for migraine in the context of integrating Chinese medicine diagnostic procedures, patients' preferences and matters relevant to clinical decision making.
The study is being undertaken at the Guangdong Provincial Hospital of Chinese Medicine (GPHCM) from December 2020 to May 2022. We anticipate that approximately 400 adult migraineurs will be enrolled and observed on their migraine severity, analgesic consumption, quality of life, anxiety, depression and insomnia at baseline and then every four weeks over 12 weeks. Treatments, diagnostic information, and patient-reported most bothersome symptoms will be collected from patient clinical records. Patient's demographic data, preferences and concerns on CHM treatments will also be gathered at baseline and be analysed. Factors related to clinical outcomes will be explored with multiple correlation and multivariable regression analyses. Effects of CHM will be evaluated using generalised estimated equation, based on clinical outcome data.
This study will provide comprehensive evidence of CHM for migraine in the context of evidence-based practice.
ChiCTR2000041003.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Computer and Information Sciences
/ Context
/ Drugs, Chinese Herbal - adverse effects
/ Headache
/ Humans
/ Insomnia
/ Medicine
/ Medicine and Health Sciences
/ Medicine, Chinese Traditional
/ Migraine
/ Migraine Disorders - drug therapy
/ Observational Studies as Topic
/ Patients
